Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
8 drugs in development
By Therapeutic Area
top 4
R&D Momentum
85/100
Pipeline Velocity
62/100
Trial Completion Rate
57/100
Pipeline Concentration
24/100
Pipeline Freshness
71/100
Strategic Signals
Activity
Last 14 days
Heightening Oncologist-Latino/a Cancer Patient Alliances (HOLA) Intervention Pilot Study
Metabolic Health, Bones and Nuts Sources of Fatty Acids During Weight Loss in Adults
DECIDE to Improve Maternal Mental Health Care Delivery
Real-time Intervention for Suicide Risk Reduction
Developing and Implementing HPV SCREENED (Self-Collection REach and ENgagement in Emergency Departments) to Improve Cancer Equity
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)